Webicina

After months of hard, collaborative work, Webicina.com just published the first version of the open access guide for pharma about using social media. While drug companies, healthcare professionals and e-patients wait for FDA guidelines on social media, with an expert crowd we created our own guidelines to serve as a basis for more detailed, extended guides.

You can download the PDF (14 pages) here!

Please feel free to download it, share it with your colleagues and join us to create an even more sophisticated second version which we can submit to the FDA. Give us feedback on Twitter through#pharmaSMguide!

The original Google Docs document contains more details, negative and positive social media-related pharma case studies as well.

Best regards,

Dr. Bertalan Mesko

Managing director and founder
Webicina LLC
info@webicina.com
http://www.webicina.com
Twitter: Berci

Related articles

• Webicina.com Social Media Story Contest: Meet The Winners! (scienceroll.com)
• Basil Strategies and Webicina partner on Doctors 2.0 & You Social Media Platform (scienceroll.com)
• Doctors 2.0 and You in Partnership with Webicina (scienceroll.com)
• Webicina.com: New design, new search engine, new era! (scienceroll.com)
• 7 GPP Stories from Social Media, week of 12/16/2011 (goodpromotionalpractices.com)
• Pharma continues to waste money on TV (worldofdtcmarketing.com)
• 21 Captivating Social Media Stats: How People Interact With Brands [INFOGRAPHIC] (hubspot.com)
• Infographic: How Social Media Marketing can contribute to the success of your Offline Business? (buzzom.com)
• Consequences of the Lack of FDA Guidance on Social Media (Reid & Senak) (scienceintelligence.wordpress.com)